D. Sanglard

J. Schrenzel, R. Zbinden, K. Boggian, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Farnesol-Induced Apoptosis in Candida albicans Is Mediated by Cdr1-p Extrusion and Depletion of Intracellular Glutathione

B. P. Krom, B. Peters, M. Shirtliff, 2011, PloS one.

Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1, CDR2, CaMDR1, and FLU1 Genes

D. Sanglard, J. Billé, O. Marchetti, 2003, Antimicrobial Agents and Chemotherapy.

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.

D. Sanglard, F. Odds, 2002, The Lancet. Infectious diseases.

MALDI-TOF MS-based drug susceptibility testing of pathogens: The example of Candida albicans and ﬂuconazole

J. Golmard, G. Snounou, C. Hennequin, 2009 .

How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems

D. Sanglard, A. Coste, F. Lamoth, 2022, Frontiers in Cellular and Infection Microbiology.

Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.

M. Arendrup, K. Nielsen, D. Perlin, 2015, The Journal of antimicrobial chemotherapy.

The Quorum-Sensing Molecules Farnesol/Homoserine Lactone and Dodecanol Operate via Distinct Modes of Action in Candida albicans

L. Levin, J. Buck, D. Sanglard, 2011, Eukaryotic Cell.

Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes.

N. Gow, B. Hube, D. Sanglard, 1998, FEMS microbiology letters.

The bZIP Transcription Factor Rca1p Is a Central Regulator of a Novel CO2 Sensing Pathway in Yeast

N. Pavelka, M. Lorenz, O. Kurzai, 2012, PLoS pathogens.

Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence

Dominique Sanglard, Jacques Bille, D. Sanglard, 2003, Molecular microbiology.

Comprehensive approach for the detection of antifungal compounds using a susceptible strain of Candida albicans and confirmation of in vivo activity with the Galleria mellonella model.

K. Gindro, L. Marcourt, S. Dorsaz, 2014, Phytochemistry.

Distinct Roles of Candida albicans Drug Resistance Transcription Factors TAC1, MRR1, and UPC2 in Virulence

Andrea Lohberger, D. Sanglard, A. Coste, 2013, Eukaryotic Cell.

The Candida albicans plasma membrane protein Rch1p, a member of the vertebrate SLC10 carrier family, is a novel regulator of cytosolic Ca2+ homoeostasis.

Linghuo Jiang, D. Sanglard, J. Geyer, 2012, The Biochemical journal.

Ultra-Performance Liquid Chromatography Mass Spectrometry and Sensitive Bioassay Methods for Quantiﬁcation of Posaconazole Plasma Concentrations after Oral Dosing (cid:1)

L. Decosterd, B. Rochat, B. Pesse, 2010 .

Resistance and tolerance mechanisms to antifungal drugs in fungal pathogens

D. Sanglard, 2003 .

Current understanding of the modes of action and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections.

D. Sanglard, J. Billé, 2002 .

A New Endogenous Overexpression System of Multidrug Transporters of Candida albicans Suitable for Structural and Functional Studies

R. Prasad, N. K. Khandelwal, D. Sanglard, 2016, Front. Microbiol..

Emerging Threats in Antifungal-Resistant Fungal Pathogens

Dominique Sanglard, D. Sanglard, 2016, Front. Med..

Participation of the ABC Transporter CDR1 in Azole Resistance of Candida lusitaniae

F. Grenouillet, D. Sanglard, Valentin Borgeat, 2021, Journal of fungi.

Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms

D. Sanglard, A. Coste, 2015, Antimicrobial Agents and Chemotherapy.

Candida glabrata mutator phenotype promotes resistance to multiple antifungal drugs

J. Sobel, S. Lockhart, Erika Shor, 2015 .

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate.

D. Denning, M. Anderson, I. Roberts, 2002, Fungal genetics and biology : FG & B.

Hijacking Transposable Elements for Saturation Mutagenesis in Fungi

D. Sanglard, S. Schrevens, 2021, Frontiers in Fungal Biology.

Germ Tubes and Proteinase Activity Contribute to Virulence of Candida albicans in Murine Peritonitis

T. Bertsch, T. Nichterlein, B. Hube, 1999, Infection and Immunity.

A novel Candida glabrata doxycycline-inducible system for in vitro/in vivo use

D. Sanglard, S. Schrevens, 2022, FEMS yeast research.

Upregulation of the Adhesin Gene EPA1 Mediated by PDR1 in Candida glabrata Leads to Enhanced Host Colonization

B. Posteraro, M. Sanguinetti, D. Sanglard, 2016, mSphere.

Isolation of the Candida tropicalis gene for P450 lanosterol demethylase and its expression in Saccharomyces cerevisiae.

C. Chen, D. Sanglard, J. C. Loper, 1987, Biochemical and biophysical research communications.

Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750

D. Sanglard, F. Barchiesi, G. Scalise, 2000, Antimicrobial Agents and Chemotherapy.

Activity of Isavuconazole and Other Azoles Against Candida Clinical Isolates and 1

D. Sanglard, A. Coste, 2015 .

Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains.

S. Kohno, D. Sanglard, P. Marichal, 1999, The Journal of antimicrobial chemotherapy.

Functional aspects of secreted Candida proteinases.

B. Hube, D. Sanglard, M. Monod, 1998, Advances in experimental medicine and biology.

Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris

D. Sanglard, A. Coste, F. Lamoth, 2022, Antimicrobial agents and chemotherapy.

Distinct Patterns of Gene Expression Associated with Development of Fluconazole Resistance in Serial Candida albicansIsolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis

T. C. White, Linda N. Lee, J. Lopez-Ribot, 1998, Antimicrobial Agents and Chemotherapy.

Voriconazole-Induced Inhibition of the Fungicidal Activity of Amphotericin B in Candida Strains with Reduced Susceptibility to Voriconazole: an Effect Not Predicted by the MIC Value Alone

O. Cars, D. Sanglard, J. Sjölin, 2011, Antimicrobial Agents and Chemotherapy.

amphotericin B in Candida strains with reduced susceptibility to

O. Cars, D. Sanglard, E. Löwdin, 2011 .

PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.

R. Prasad, D. Sanglard, Monika Sharma, 2010, Microbiology.

Functional Analysis of cis- and trans-Acting Elements of the Candida albicans CDR2 Promoter with a Novel Promoter Reporter System

C. Bauser, B. Rohde, D. Sanglard, 2009, Eukaryotic Cell.

Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland

J. Schrenzel, K. Gindro, D. Sanglard, 2018, Antimicrobial Agents and Chemotherapy.

Azole resistance of Aspergillus fumigatus isolates from the environment and the clinic in Switzerland

J. Schrenzel, K. Gindro, D. Sanglard, 2018 .

Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans

M. Bard, D. Sanglard, N. Lees, 1990, Antimicrobial Agents and Chemotherapy.

Repercussion of a deficiency in mitochondrial ß-oxidation on the carbon flux of short-chain fatty acids to the peroxisomal ß-oxidation cycle in Aspergillus nidulans.

Y. Poirier, D. Sanglard, Pasqualina Magliano, 2010, Biochimica et biophysica acta.

The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors.

A. Telenti, D. Sanglard, M. Monod, 1999, Dermatology.

Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates.

D. Sanglard, I. Meneau, 2005, Medical mycology.

In vivo visualization of Candida albicans infections

S. Dorsaz, D. Sanglard, A. Coste, 2017 .

Clinical relevance of mechanisms of antifungal drug resistance in yeasts.

D. Sanglard, 2002, Enfermedades infecciosas y microbiologia clinica.

Virus-Infected Patients from Human Immunodeficiency High-Level Fluconazole Resistance Isolated Strains Displaying Candida albicans Resistance to Azole Antifungal Agents in Prevalence of Molecular Mechanisms of

J. Lopez-Ribot, D. Sanglard, T. Patterson, 2001 .

Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.

G. Fadda, B. Posteraro, M. Sanguinetti, 2006, The Journal of antimicrobial chemotherapy.

Overcoming the heterologous bias: an in vivo functional analysis of multidrug efflux transporter, CgCdr1p in matched pair clinical isolates of Candida glabrata.

R. Prasad, D. Sanglard, Monika Sharma, 2011, Biochemical and biophysical research communications.

Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes.

N. Gow, B. Hube, D. Sanglard, 1998, FEMS microbiology letters.

Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models

M. Arendrup, D. Sanglard, K. Astvad, 2018, Antimicrobial Agents and Chemotherapy.

Isolation and characterization of a secreted metalloprotease of Aspergillus fumigatus

J. Latgé, D. Sanglard, M. Monod, 1993, Infection and immunity.

Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods

T. Buclin, L. Decosterd, T. Calandra, 2006, Antimicrobial Agents and Chemotherapy.

Asymmetric distribution of phosphatidylethanolamine in C. albicans : possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily

V. Gupta, C. M. Gupta, D. Sanglard, 1999, Yeast.

Molecular Mechanisms of Action of Herbal Antifungal Alkaloid Berberine, in Candida albicans

F. Devaux, R. Prasad, N. K. Khandelwal, 2014, PloS one.

Resistance of human fungal pathogens to antifungal drugs.

Dominique Sanglard, D. Sanglard, 2002, Current opinion in microbiology.

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

K. Kuchler, D. Sanglard, M. Monod, 1995, Antimicrobial agents and chemotherapy.

Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

D. Sanglard, M. Monod, J. Billé, 1997, Microbiology.

Mechanisms of Multidrug Resistance in Fungal Pathogens

D. Sanglard, S. Ferrari, 2010 .

Worldwide emergence of resistance to antifungal drugs challenges human health and food security

M. Fisher, N. Hawkins, S. Gurr, 2018, Science.

The CRH Family Coding for Cell Wall Glycosylphosphatidylinositol Proteins with a Predicted Transglycosidase Domain Affects Cell Wall Organization and Virulence of Candida albicans*

C. D. de Koster, F. Klis, D. Sanglard, 2006, Journal of Biological Chemistry.

Mechanisms of Antifungal Drug Resistance.

L. Cowen, P. D. Rogers, D. Perlin, 2015, Cold Spring Harbor perspectives in medicine.

CaALK8, an alkane assimilating cytochrome P450, confers multidrug resistance when expressed in a hypersensitive strain of Candida albicans

V. Gupta, R. Prasad, M. Raymond, 2001, Yeast.

Multiple resistance mechanisms to azole antifungals in yeast clinical isolates.

D. Sanglard, J. Billé, F. Ischer, 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography.

L. Decosterd, D. Sanglard, P. Majcherczyk, 2002, Journal of pharmaceutical and biomedical analysis.

Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.

E. Mellado, D. Sanglard, M. Cuenca‐Estrella, 2011, International journal of antimicrobial agents.

Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata

G. Fadda, B. Posteraro, M. Sanguinetti, 2009, Journal of Clinical Microbiology.

Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.

O. Lortholary, D. Sanglard, D. Valeyre, 2006, Journal of medical microbiology.

Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice

B. Posteraro, M. Sanguinetti, D. Sanglard, 2011, Antimicrobial Agents and Chemotherapy.

Sensitive Bioassay for Determination of Fluconazole Concentrations in Plasma Using a Candida albicans Mutant Hypersusceptible to Azoles

D. Sanglard, P. Majcherczyk, J. Billé, 2001, Antimicrobial Agents and Chemotherapy.

Ultra-Performance Liquid Chromatography Mass Spectrometry and Sensitive Bioassay Methods for Quantification of Posaconazole Plasma Concentrations after Oral Dosing

L. Decosterd, B. Rochat, B. Pesse, 2010, Antimicrobial Agents and Chemotherapy.

The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata

G. Fadda, B. Posteraro, M. Sanguinetti, 2008, Molecular microbiology.

Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.

D. Sanglard, E. Delarze, 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis

S. Donnelly, D. Sanglard, G. Moran, 1998, Antimicrobial Agents and Chemotherapy.

Camphor and Eucalyptol—Anticandidal Spectrum, Antivirulence Effect, Efflux Pumps Interference and Cytotoxicity

I. Ferreira, D. Sanglard, J. Glamočlija, 2021, International journal of molecular sciences.

Cytochrome P450 in Unicellular Organisms

O. Käppeli, D. Sanglard, 1993 .

Identification and Mode of Action of a Plant Natural Product Targeting Human Fungal Pathogens

K. Gindro, S. Dorsaz, H. Riezman, 2017, Antimicrobial Agents and Chemotherapy.

HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases.

A. Telenti, I. Meyer, D. Sanglard, 1999, The Journal of investigative dermatology.

Persistence of Candida albicans in the Oral Mucosa Induces a Curbed Inflammatory Host Response That Is Independent of Immunosuppression

M. Pagni, S. Altmeier, S. Leibundgut-Landmann, 2019, Front. Immunol..

Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors

D. Sanglard, M. Monod, J. Billé, 1996, Antimicrobial agents and chemotherapy.

Multiplicity of genes encoding secreted aspartic proteinases in Candida species

B. Hube, D. Sanglard, M. Monod, 1994, Molecular microbiology.

Secreted Aspartic Proteinase Family ofCandida tropicalis

U. Reichard, D. Sanglard, M. Monod, 2001, Infection and Immunity.

The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages

K. Boggian, S. Beggah, D. Sanglard, 1998, Molecular microbiology.

Interrogation of related clinical pan-azole resistant Aspergillus fumigatus strains – G138C, Y431C and G434C SNPs in cyp51A, Upregulation of cyp51A and integration and activation of transposon Atf1 into cyp51A promoter.

G. Robson, D. Denning, M. Anderson, 2011 .

Evolution of Drug Resistance in Experimental Populations of Candida albicans

L. Cowen, James B. Anderson, L. Kohn, 2000, Journal of bacteriology.

A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.

D. Sanglard, J. Billé, D. Calabrese, 2000, Microbiology.

Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling

Ashutosh Kumar Singh, T. C. White, C. d’Enfert, 2017, The Journal of Biological Chemistry.

Identification and characterization of additional members of the cytochrome P450 multigene family CYP52 of Candida tropicalis.

W. Seghezzi, A. Fiechter, D. Sanglard, 1992, DNA and cell biology.

Candida yeast long chain fatty alcohol oxidase is a c-type haemoprotein and plays an important role in long chain fatty acid metabolism.

Alison G. Smith, D. Sanglard, S. Vanhanen, 2005, Biochimica et biophysica acta.

Characterization of the alkane-inducible cytochrome P450 (P450alk) gene from the yeast Candida tropicalis: identification of a new P450 gene family.

D. Sanglard, J. C. Loper, 1989, Gene.

Novel Macrocyclic Amidinoureas: Potent Non-Azole Antifungals Active against Wild-Type and Resistant Candida Species.

M. Botta, B. Posteraro, M. Sanguinetti, 2013, ACS medicinal chemistry letters.

Acid proteinase secreted by Candida tropicalis: functional analysis of preproregion cleavages in C. tropicalis and Saccharomyces cerevisiae.

M. Quadroni, D. Sanglard, M. Monod, 1996, Microbiology.

Isolation and nucleotide sequence of the extracellular acid protease gene (ACP) from the yeast Candida tropicalis

R. Falchetto, D. Sanglard, M. Monod, 1991, FEBS letters.

Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter.

K. Kuchler, D. Sanglard, R. Egner, 1998, Molecular biology of the cell.

Identification and Functional Characterization of Rca1, a Transcription Factor Involved in both Antifungal Susceptibility and Host Response in Candida albicans

S. Pradervand, K. Harshman, D. Sanglard, 2012, Eukaryotic Cell.

Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models

D. Sanglard, A. Coste, F. Ischer, 2015, Front. Microbiol..

Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans

J. Ernst, D. Sanglard, D. Bockmühl, 2000, Molecular microbiology.

Mechanisms of Drug Resistance in Candida albicans

D. Sanglard, 2017 .

Pivotal Role for a Tail Subunit of the RNA Polymerase II Mediator Complex CgMed2 in Azole Tolerance and Adherence in Candida glabrata

V. Srivastava, R. Kaur, D. Sanglard, 2014, Antimicrobial Agents and Chemotherapy.

Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence

G. Fadda, C. Bauser, B. Posteraro, 2009, PLoS pathogens.

TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2

D. Sanglard, A. Coste, J. Billé, 2004, Eukaryotic Cell.

Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans.

D. MacCallum, B. Hube, D. Sanglard, 2005, Microbiology.

Candida albicans commensalism in the oral mucosa is favoured by limited virulence and metabolic adaptation

M. Pagni, C. d’Enfert, S. Altmeier, 2021, bioRxiv.

RNA Enrichment Method for Quantitative Transcriptional Analysis of Pathogens In Vivo Applied to the Fungus Candida albicans

M. Pagni, S. Pradervand, D. Sanglard, 2015, mBio.

Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance.

D. Sanglard, Z. Kozovska, A. Coste, 2006, Microbiology.

Roles of Cellular Respiration, CgCDR1, and CgCDR2 in Candida glabrata Resistance to Histatin 5

D. Sanglard, F. Oppenheim, E. Helmerhorst, 2006, Antimicrobial Agents and Chemotherapy.

Isolation of the alkane inducible cytochrome P450 (P450alk) gene from the yeast Candida tropicalis.

C. Chen, D. Sanglard, J. C. Loper, 1987, Biochemical and biophysical research communications.

Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p

D. Sanglard, S. T. Coleman, Xiaoting Zhang, 2000, Molecular microbiology.

Condition-specific series of metabolic sub-networks and its application for gene set enrichment analysis

T. Van Du Tran, Sébastien Moretti, Marco Pagni, 2017, bioRxiv.

Investigating Candida glabrata Urinary Tract Infections (UTIs) in Mice Using Bioluminescence Imaging

D. Sanglard, S. Schrevens, 2021, Journal of fungi.

Single yeast cell nanomotions correlate with cellular activity

H. Sahli, R. Willaert, G. Dietler, 2020, Science Advances.

In Vivo Systematic Analysis of Candida albicans Zn2-Cys6 Transcription Factors Mutants for Mice Organ Colonization

D. Sanglard, P. Vandeputte, A. Coste, 2011, PloS one.

Comparative Genomics Suggests that the Fungal Pathogen Pneumocystis Is an Obligate Parasite Scavenging Amino Acids from Its Host's Lungs

Patrick Taffé, Laurent Keller, Marco Pagni, 2010, PloS one.

Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans.

Rupinder Kaur, Pranab K Mukherjee, Neeraj Chauhan, 2014, The Biochemical journal.

Novel Acid Phosphatase in Candida glabrata Suggests Selective Pressure and Niche Specialization in the Phosphate Signal Transduction Pathway

D. Wykoff, D. Sanglard, Christine L Kerwin, 2010, Genetics.

Finding the needle in a haystack: Mapping antifungal drug resistance in fungal pathogen by genomic approaches

D. Sanglard, 2019, PLoS pathogens.

High-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal Ergolines

R. Riedl, D. Hoepfner, V. Pries, 2016, PLoS genetics.

Anti-Candida Cassane-Type Diterpenoids from the Root Bark of Swartzia simplex.

Mahabir P. Gupta, K. Gindro, L. Marcourt, 2015, Journal of natural products.

Controlled regioselectivity of fatty acid oxidation by whole cells producing cytochrome P450BM-3 monooxygenase under varied dissolved oxygen concentrations.

M. Wubbolts, B. Witholt, D. Sanglard, 1999, Biotechnology and Bioengineering.

Inhibiting Fungal Multidrug Resistance by Disrupting an Activator-Mediator Interaction

Maurizio Sanguinetti, Gerhard Wagner, Haribabu Arthanari, 2016, Nature.

Yeast Nanometric Scale Oscillations Highlights Fibronectin Induced Changes in C. albicans

R. Willaert, G. Dietler, D. Sanglard, 2020, Fermentation.

Cloning and sequencing of two Candida parapsilosis genes encoding acid proteases.

R. Falchetto, D. Sanglard, M. Monod, 1993, Journal of general microbiology.

Acid proteinase secreted by Candida tropicalis: virulence in mice of a proteinase negative mutant.

D. Sanglard, M. Monod, G. Togni, 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Optimization of Candida tropicalis cytochrome P450alk gene expression in Saccharomyces cerevisiae with continuous cultures

O. Käppeli, A. Fiechter, D. Sanglard, 1991, Applied Microbiology and Biotechnology.

Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy

D. Sanglard, S. Giulieri, O. Marchetti, 2015, Antimicrobial Agents and Chemotherapy.

TAC 1 , Transcriptional Activator of CDR Genes , Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR 1 and CDR 2 †

D. Sanglard, A. Coste, J. Billé, 2004 .

Characterization of the Aspergillus nidulans biotin biosynthetic gene cluster and use of the bioDA gene as a new transformation marker.

Y. Poirier, D. Sanglard, M. Flipphi, 2011, Fungal genetics and biology : FG & B.

Characterization of a second alkane-inducible cytochrome P450-encoding gene, CYP52A2, from Candida tropicalis.

W. Seghezzi, A. Fiechter, D. Sanglard, 1991, Gene.

Heterogeneity within the alkane‐inducible cytochrome P450 gene family of the yeast Candida tropicalis

A. Fiechter, D. Sanglard, 1989, FEBS letters.

Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound.

P. Visca, M. Botta, B. Posteraro, 2016, Journal of medicinal chemistry.

A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance

D. Sanglard, J. Billé, M. Micheli, 2002, Molecular microbiology.

Investigation into the molecular mechanisms of itraconazole resistance in Candida dubliniensis

S. Kelly, C. Jackson, D. Sanglard, 2003 .

Gain-of-Function Mutations in PDR1, a Regulator of Antifungal Drug Resistance in Candida glabrata, Control Adherence to Host Cells

S. Leibundgut-Landmann, D. Sanglard, F. Ischer, 2013, Infection and Immunity.

Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance.

D. Sanglard, A. Coste, I. Meneau, 2016, Medical mycology.

PRODUCTION OF ALKANEDIOIC ACIDS MONOOXYGENASE: OXIDATION OF 16-HYDROXYHEXADECANOIC ACID TO BY CYTOCHROME P45b~3 HEXADECANE-l,16-DIOIC ACID

D. Sanglard, Marcel G. WUBBOLTSa, 1999 .

Analysis of Natural Variants of the Human Immunodeficiency Virus Type 1 gag-pol Frameshift Stem-Loop Structure

A. Telenti, M. Muñoz, Gilbert GREUB, 2002, Journal of Virology.

Insights in the molecular mechanisms of an azole stress adapted laboratory-generated Aspergillus fumigatus strain.

D. Sanglard, I. Mouyna, A. Coste, 2021, Medical mycology.

Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris

D. Sanglard, A. Coste, F. Lamoth, 2021, Microbiology spectrum.

Novel ERG11 and TAC1b Mutations Associated with Azole Resistance in Candida auris

D. Sanglard, A. Coste, F. Lamoth, 2021, Antimicrobial Agents and Chemotherapy.

Disruption of the gene encoding the secreted acid protease (ACP) in the yeast Candida tropicalis

D. Sanglard, M. Monod, P. Viragh, 1992 .

Machine Learning Approach for Candida albicans Fluconazole Resistance Detection Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

L. Cerutti, Gilbert GREUB, Margot Delavy, 2020, Frontiers in Microbiology.

Function Analysis of MBF1, a Factor Involved in the Response to Amino Acid Starvation and Virulence in Candida albicans

M. Pagni, D. Sanglard, A. Coste, 2021, Frontiers in Fungal Biology.

Novel Approaches for Fungal Transcriptomics from Host Samples

D. Sanglard, Sara Amorim-Vaz, 2016, Front. Microbiol..

Characterization of a New Clinical Yeast Species, Candida tunisiensis sp. nov., Isolated from a Strain Collection from Tunisian Hospitals

V. Hofstetter, M. Groenewald, D. Sanglard, 2012, Journal of Clinical Microbiology.

Host Cells Candida glabrata, Control Adherence to Regulator of Antifungal Drug Resistance in , a PDR1 Gain-of-Function Mutations in

D. Sanglard, F. Ischer, L. Vale-Silva, 2014 .

Signaling Pathways Governing the Caspofungin Paradoxical Effect in Aspergillus fumigatus

F. Morio, D. Sanglard, N. Papon, 2020, mBio.

Link between Heat Shock Protein 90 and the Mitochondrial Respiratory Chain in the Caspofungin Stress Response of Aspergillus fumigatus

D. Sanglard, F. Lamoth, D. Bachmann, 2019, Antimicrobial Agents and Chemotherapy.

Inhibitors of Ergosterol Biosynthesis as Antifungal Agents

D. Sanglard, P. Hartman, 1997, Current Pharmaceutical Design.

In Vitro Effect of Malachite Green on Candida albicans Involves Multiple Pathways and Transcriptional Regulators UPC2 and STP2

Ashutosh Kumar Singh, F. Devaux, R. Prasad, 2011, Antimicrobial Agents and Chemotherapy.

Pneumocystis jiroveci Dihydropteroate Synthase Polymorphisms Confer Resistance to Sulfadoxine and Sulfanilamide in Saccharomyces cerevisiae

P. Hauser, D. Sanglard, J. Billé, 2004, Antimicrobial Agents and Chemotherapy.

Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans.

D. Hess, B. Hube, D. Sanglard, 1998, Microbiology.

New Data on the In Vitro Activity of Fenticonazole against Fluconazole-Resistant Candida Species

B. Posteraro, M. Sanguinetti, D. Sanglard, 2020, Antimicrobial Agents and Chemotherapy.

Fenticonazole against Fluconazole-Resistant Candida Species: New In Vitro Activity Data.

B. Posteraro, M. Sanguinetti, D. Sanglard, 2020, Antimicrobial agents and chemotherapy.

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species

E. Berkow, K. Barker, P. D. Rogers, 2017, Frontiers in microbiology.

Revealing the astragalin mode of anticandidal action

D. Sanglard, J. Glamočlija, M. Soković, 2020, EXCLI journal.

Performance and gut permeability of post-weaned piglets are influenced by different sources of lignocellulose fiber

D. Sanglard, S. Hirtenlehner, H.M.C. Cardoso, 2023, Livestock Science.

MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole

J. Golmard, G. Snounou, C. Hennequin, 2009, Proteomics.

Condition-specific series of metabolic sub-networks and its application for gene set enrichment analysis

M. Pagni, D. Sanglard, S. Moretti, 2017, bioRxiv.

Gain-of-Function Mutations in PDR1, a Regulator of Antifungal Drug Resistance in Candida glabrata, Control Adherence to Host Cells

S. Leibundgut-Landmann, D. Sanglard, F. Ischer, 2013, Infection and Immunity.

Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice

B. Posteraro, M. Sanguinetti, D. Sanglard, 2011, Antimicrobial Agents and Chemotherapy.

Upc2-mediated mechanisms of azole resistance in Candida auris

D. Sanglard, A. Coste, Danielle Brandalise, 2023, bioRxiv.

Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.

D. Sanglard, R. Rautemaa, P. Bowyer, 2010, The Journal of antimicrobial chemotherapy.

Novel Acid Phosphatase in Candida glabrata Suggests Selective Pressure and Niche Specialization in the Phosphate Signal Transduction Pathway

D. Wykoff, D. Sanglard, Christine L Kerwin, 2010, Genetics.

Production of chiral hydroxy long chain fatty acids by whole cell biocatalysis of pentadecanoic acid with an E. coli recombinant containing cytochrome P450BM-3 monooxygenase

M. Wubbolts, B. Witholt, D. Sanglard, 1998 .

Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.

M. Ramsdale, D. Sanglard, A. Coste, 2008, Microbiology.